Eric A. Dietrich, PharmD, BCPS

Controversies in Clinical Care
Controversies in Clinical Care
Is Cross-Reactivity of Concern With Sulfa-Containing Medications?
01/21/2016
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Allergies to sulfa-containing drugs are common and lead to significant concern regarding alternative medications as well as cross-reactivity.
01/21/2016
Controversies in Clinical Care
Controversies in Clinical Care
Is Aspirin an Alternative Therapy for Venous Thromboembolism Prevention?
12/18/2019
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
The management of venous thromboembolism has dramatically changed over the past 5 to 10 years. With the advent of direct-acting oral...
12/18/2019
Anticoagulant
Anticoagulant
How to Talk to Patients About the Novel Oral Anticoagulants
12/12/2014
Eric A. Dietrich, PharmD, BCPS
Over the past couple of years 3 novel oral anticoagulants (NOACs) have been FDA approved: dabigatran (Pradaxa, Boehringer Ingelheim), rivaroxaban (Xarelto, Janssen), and apixaban. Originally approved for...
12/12/2014
Controversies in Clinical Care
Controversies in Clinical Care
Choosing an SGLT-2 Inhibitor for a Patient With Type 2 Diabetes: Which Agent (if Any) Is Best?
10/31/2016
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Three SGLT-2 inhibitors are available in the United States: canagliflozin, dapagliflozin, and empagliflozin. All 3 are brand-name, are administered orally once daily, and lead to similar hemoglobin A1c...
10/31/2016
Corticosteroid
Corticosteroid
Corticosteroids in the Setting of Community-Acquired Pneumonia
12/15/2015
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Systemic corticosteroids are commonly prescribed to treat acute exacerbations of respiratory diseases, such as asthma and chronic obstructive pulmonary disease.
12/15/2015
Controversies in Clinical Care
Controversies in Clinical Care
Antibiotics for Acute Bacterial Prostatitis: Which Agent, and for How Long?
10/01/2019
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
JH is a 67-year-old man with a history of hypertension and depression who presents dysuria, increased urinary frequency, and suprapubic pain.
10/01/2019
Diabetes Q&A
Diabetes Q&A
When Can Intervals Between INR Checks Be Extended?
11/18/2014
Eric A. Dietrich, PharmD, BCPS
The CHEST guidelines recommend monitoring the INR every 4 weeks in most patients. However, in those patients who have been stable on warfarin therapy for at least 3 months, CHEST suggests that it is...
11/18/2014
Controversies in Clinical Care
Controversies in Clinical Care
Probiotics for the Prevention of Antibiotic-Associated Diarrhea and Clostridium difficile
10/04/2016
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
JS is a 53-year-old man with a history of hypertension and dyslipidemia who presents with community-acquired pneumonia. Upon discussion, he asks whether he should also take a probiotic while also taking his...
10/04/2016
Cardiovascular Diseases
Cardiovascular Diseases
Is a Potential Drug–Drug Interaction with Clopidogrel of Concern?
11/16/2015
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Dual antiplatelet therapy (DAPT) has become a mainstay in the secondary prevention of cardiovascular (CV) events in patients with a recent history of myocardial infarction (MI) or recent percutaneous...
11/16/2015
Controversies in Clinical Care
Controversies in Clinical Care
Intra-Articular Steroids for a Patient With Osteoarthritis Knee Pain: Risks and Benefits
07/31/2019
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
The practice of therapeutic injections of corticosteroids has been a longstanding procedure to relieve pain and improve functioning in patients with knee osteoarthritis.
07/31/2019